Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes
1 other identifier
observational
250
1 country
2
Brief Summary
The purpose of this study is to assess correlation between recurrent patella dislocation and genetic polymorphism rs1800012 of the COL1A1 Gene and rs12722 of the COL5A1 Gene.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 28, 2023
CompletedFirst Posted
Study publicly available on registry
March 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedApril 4, 2024
October 1, 2022
1 year
February 28, 2023
April 3, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Patients with recurrent patellar dislocation
Patients with recurrent patellar dislocation
2022-2023
Control group without obvious joint hipermobility
Control group without obvious joint hipermobility
2022-2023
Study Arms (2)
Recurrent patellar dislocation group
50 patients with recurrent patellar dislocation and without any genetic disorders.
Patients without joint hipermobility
200 patients without recurrent patellar dislocation and genetic disorders.
Interventions
COL1A1 or COL5A1 genetic test
Based on Beighton scale.
Eligibility Criteria
Patients between 7 and 17 years old with recurrent dislocation of the patella without genetic diseases.
You may qualify if:
- First-time diagnosed or recurrent patellar dislocation patient from 7 to 17 age years old.
You may not qualify if:
- Patient's age under 7.
- Presence of genetic diseases such as: Down's syndrome or Marfan's syndrome.
- Metabolic disorders.
- Previous knee surgeries.
- Cartilage and bone fractures in the knee.
- No consent for examination from the legal guardian.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Krzysztof Małecki
Lodz, Lodzkie Voivodeship, 93-160, Poland
Krzysztof Małecki
Lodz, Lodzkie Voivodeship, 93-338, Poland
Biospecimen
Blood sample or oral epithelial swab.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Krzysztof Małecki
PMMHRI
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2023
First Posted
March 10, 2023
Study Start
April 1, 2022
Primary Completion
April 1, 2023
Study Completion
December 20, 2023
Last Updated
April 4, 2024
Record last verified: 2022-10